应用低分子肝素抗凝。
治疗组应用低分子肝素联合尿激酶，对照组仅用扩容治疗。
In the treating group, LMWH combined with urokinase were given, while in the control group merely hypervolemic treatment was given.
结论应用低分子肝素联合尿激酶治疗频发TIA是一种有效、安全的治疗方法。
Conclusion The use of LMWH combined with urokinase in treating recurrent TIA was an efficacious treatment with good security.
目的了解低分子肝素与阿魏酸钠联合应用治疗不稳定型心绞痛的疗效，提高不稳定型心绞痛治疗效果。
Objective to know the effect of therapeutic alliance of low molecular heparin and sodium ferulate on unstable angina pectoris and improve the treatment effect of unstable angina pectoris.
目的：观察奥扎格雷钠、低分子肝素钠联合应用治疗进展性脑梗死的临床疗效。
AIM: To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.
结论使用肠溶阿司匹林和低分子肝素钙联合治疗急性脑梗塞疗效好，使用简便、安全、经济，可在临床予推广应用。
Conclusion it is quite effective, convenient, safe, economical and commendatory to use aspirin and low molecular weight heparin in acute cerebral infarction therapy.
目的探讨低分子肝素(LMWH)在冠状动脉支架术中的应用价值及安全性。
Objective To explore the application of low-molecular-weight heparin (LMWH) in the procedure of coronary stent implantation.
小剂量低分子肝素、胃肠外营养及生长抑素的联合应用具有较佳的疗效。
Small dosage of low molecular weight heparin, parenteral nutritional support and somatostatin therapy have the therapeutical effects to some extent.
目的观察低分子肝素钙、阿司匹林及其联合应用治疗急性脑梗死的疗效及其安全性。
OBJECTIVE To study the efficacy and safety of low-molecular-weight heparin calcium and aspirin on treating acute cerebral infarction.
所有的病人在大腿上应用止血带、预防性应用抗生素、低分子肝素抗凝。
A thigh tourniquet, prophylactic intravenous antibiotics, and low-molecular-weight heparin anticoagulation were used in all patients.
所有的病人在大腿上应用止血带、预防性应用抗生素、低分子肝素抗凝。
A thigh tourniquet, prophylactic intravenous antibiotics, and low-molecular-weight heparin anticoagulation were used in all patients.
应用推荐